TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31100620

Group type: COMPARATOR
Intervention: n-3 PUFA supplementation
Number of subjects: 484

Group type: COMPARATOR
Intervention: Diet counselling
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: LBP levels above median
Number of subjects: 484

Group type: EXPERIMENTAL
Intervention: sCD14 levels above median
Number of subjects: 484
Study: 28286376

Group type: EXPERIMENTAL
Intervention: Active NPPT (ANPPT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Barker's Vacuum Pack NPPT (BVP)
Number of subjects: 44
Study: 25828109

Group type: EXPERIMENTAL
Intervention: Bare Metal Stents (BMS)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Biolimus Eluting Stents (BES)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (BMS and BES)
Number of subjects: 43
Study: 23314556

Group type: EXPERIMENTAL
Intervention: B vitamins (500 µg folic acid, 500 µg vitamin B12, 50 mg vitamin B6), 1200 IU vitamin D, and 456 mg calcium
Number of subjects: 50
Study: 21911018

Group type: EXPERIMENTAL
Intervention: Chewing gum
Number of subjects: 0

Group type: COMPARATOR
Intervention: No chewing (control)
Number of subjects: 0
Study: 19817285

Group type: EXPERIMENTAL
Intervention: Debridement under arthroscopy (Group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Local block therapy (Group B)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Open operation (Group C)
Number of subjects: 90
Study: 17100372

Group type: EXPERIMENTAL
Intervention: Halogen light stimulation test (LST)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control (NST)
Number of subjects: 176
Study: 15531662

Group type: EXPERIMENTAL
Intervention: Oral ethinyl estradiol
Number of subjects: 292

Group type: COMPARATOR
Intervention: Transdermal 17beta-estradiol
Number of subjects: 292

Group type: COMPARATOR
Intervention: Cyproterone acetate
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Parenteral testosterone
Number of subjects: 292

Group type: COMPARATOR
Intervention: Anastrozole
Number of subjects: 292

Group type: COMPARATOR
Intervention: Oral contraceptives
Number of subjects: 292
Study: 11419712

Group type: EXPERIMENTAL
Intervention: Grated fresh Golden Delicious apple (DBPCFC)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Open food challenge with whole fresh apple
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Specific IgE against Golden Delicious apple
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo reaction
Number of subjects: 27

Group type: COMPARATOR
Intervention: Skin prick test (SPT), leukocyte histamine release (HR), immunoblotting experiments
Number of subjects: 27
Study: 9039199

Group type: EXPERIMENTAL
Intervention: Butenafine 1% cream applied once daily for 4 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Vehicle applied once daily for 4 weeks
Number of subjects: 80
Study: 7911176

Group type: EXPERIMENTAL
Intervention: Mediterranean alpha-linolenic acid-rich diet
Number of subjects: 605

Group type: COMPARATOR
Intervention: Usual post-infarct prudent diet
Number of subjects: 605
Study: 3594491

Group type: EXPERIMENTAL
Intervention: Adjuvant oral Bestatin treatment (30 mg daily for at least 1 year)
Number of subjects: 151

Group type: COMPARATOR
Intervention: No Bestatin (Control)
Number of subjects: 151
Study: 31945065

Group type: EXPERIMENTAL
Intervention: Alectinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 0
Study: 30782906

Group type: EXPERIMENTAL
Intervention: 2 mg/kg adrecizumab
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 4 mg/kg adrecizumab
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Adrecizumab (2 and 4 mg/kg)
Number of subjects: 300
Study: 28446656

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 3802

Group type: COMPARATOR
Intervention: Diabetes support and education control
Number of subjects: 3802
Study: 25831450

Group type: EXPERIMENTAL
Intervention: Registered Dietitian
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Counselor
Number of subjects: 87

Group type: COMPARATOR
Intervention: Wait-list Control
Number of subjects: 87
Study: 23167309

Group type: EXPERIMENTAL
Intervention: Dispensed analgesia (group 'dispensed')
Number of subjects: 200

Group type: COMPARATOR
Intervention: Advised without analgesia (group 'advised')
Number of subjects: 200
Study: 21305612

Group type: EXPERIMENTAL
Intervention: Escitalopram (ESC)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Duloxetine (DUL)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Both treatments (ESC and DUL)
Number of subjects: 43
Study: 18223503

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt (100 mL supplemented yogurt per day for 15 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control yogurt (100 mL unsupplemented yogurt per day for 15 days)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control yogurt
Number of subjects: 24
Study: 16633813

Group type: EXPERIMENTAL
Intervention: Single-session, small-group stress management program
Number of subjects: 300

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 300
Study: 14562640

Group type: EXPERIMENTAL
Intervention: Unkei-to (7.5 g/d)
Number of subjects: 103
Study: 10632423

Group type: EXPERIMENTAL
Intervention: follitropin-alpha (Gonal-F)
Number of subjects: 44

Group type: COMPARATOR
Intervention: follitropin-beta (Puregon)
Number of subjects: 44
Study: 9235004

Group type: EXPERIMENTAL
Intervention: 1.5 micrograms/kg fentanyl
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1.5 micrograms/kg fentanyl plus 3 micrograms/kg clonidine
Number of subjects: 10
Study: 1344707

Group type: EXPERIMENTAL
Intervention: Camit S1 data analysis
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional log-book method
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Camit S2
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cadmo simulation programs
Number of subjects: 19
Study: 3898291

Group type: EXPERIMENTAL
Intervention: Thymopentin (50 mg, administered 3 times a week, subcutaneously for 6 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (administered 3 times a week, subcutaneously for 6 weeks)
Number of subjects: 36
Study: 31058892

Group type: EXPERIMENTAL
Intervention: Soccer heading (n = 18) - executed 10 headers with soccer balls projected at a velocity of 25 mph over 10 min.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Kicking (n = 16) - followed the same protocol with 10 kicks.
Number of subjects: 34
Study: 30172453

Group type: EXPERIMENTAL
Intervention: Conformal radiotherapy (45 Gy/25 fractions plus a boost) and concomitant fluorouracil and cisplatin at weeks 1 and 5
Number of subjects: 387
Study: 27243035

Group type: EXPERIMENTAL
Intervention: Vigorous Exercise (VE)
Number of subjects: 20
Study: 25407279

Group type: EXPERIMENTAL
Intervention: Lesogaberan 30 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Lesogaberan 90 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Lesogaberan 120 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Lesogaberan 240 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 23302735

Group type: EXPERIMENTAL
Intervention: 25 mg mifepristone once a day for 2 days + 200 µg misoprostol 48 hours later (G1 group)
Number of subjects: 200

Group type: COMPARATOR
Intervention: 150 mg mifepristone + 600 µg misoprostol 48 hours later (G2 group)
Number of subjects: 200
Study: 20575918

Group type: EXPERIMENTAL
Intervention: Endobutton (n=13)
Number of subjects: 29

Group type: COMPARATOR
Intervention: TransFix (n=16)
Number of subjects: 29
Study: 18035097

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Vascular brachytherapy
Number of subjects: 384
Study: 16095463

Group type: EXPERIMENTAL
Intervention: 1000 ml 3% dextran 60 solution
Number of subjects: 110

Group type: COMPARATOR
Intervention: 1000 ml acetated Ringer's solution
Number of subjects: 110
Study: 12034106

Group type: EXPERIMENTAL
Intervention: Aerosol measles and rubella (MR) vaccine
Number of subjects: 562

Group type: COMPARATOR
Intervention: Subcutaneous measles and rubella (MR) vaccine
Number of subjects: 562
Study: 10422534

Group type: EXPERIMENTAL
Intervention: Protected conditions (wearing Kevlar army helmet and earplugs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bare‐head control condition
Number of subjects: 0
Study: 7555467

Group type: EXPERIMENTAL
Intervention: Meloxicam (7.5 mg/day)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Meloxicam (15 mg/day)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Piroxicam (20 mg/day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: NSAID-induced mucosal damage
Number of subjects: 51
Study: 2217669

Group type: EXPERIMENTAL
Intervention: Antibiotics before the procedure
Number of subjects: 515

Group type: COMPARATOR
Intervention: Control (no antibiotics)
Number of subjects: 515
Study: 83072

Group type: EXPERIMENTAL
Intervention: Transfer factor
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo preparation
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Transfer factor (after crossover from placebo)
Number of subjects: 6
Study: 31204849

Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28707431

Group type: EXPERIMENTAL
Intervention: T. foenum‐graecum de‐husked seed extract, 600 mg per day for 12 weeks
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 25536539

Group type: EXPERIMENTAL
Intervention: Talk Test (TT) - Last Positive (LP) stage
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Talk Test (TT) - Equivocal (EQ) stage
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Talk Test (TT) - Negative (NEG) stage
Number of subjects: 16
Study: 23392686

Group type: EXPERIMENTAL
Intervention: Sphingosine-1-phosphate (S1P)
Number of subjects: 0

Group type: COMPARATOR
Intervention: S1P(3)(-/-) mice
Number of subjects: 0

Group type: COMPARATOR
Intervention: S1P(1)(fl/fl) mice and SNS-S1P(1)(-/-) mice
Number of subjects: 0
Study: 21271379

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery 3 days after SEMS placement
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery 10 days after SEMS placement
Number of subjects: 49

Group type: COMPARATOR
Intervention: Emergent open surgery
Number of subjects: 49
Study: 20079135

Group type: EXPERIMENTAL
Intervention: Fentanyl 1 microg/kg bolus followed by continuous infusion of 0.1 microg x kg(‐1) x min(‐1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Remifentanil 1 microg/kg bolus followed by continuous infusion of 0.1 microg x kg(‐1) x min(‐1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.1 microg/kg bolus followed by continuous infusion of 0.01 microg x kg(‐1) x min(‐1)
Number of subjects: 90
Study: 17904457

Group type: EXPERIMENTAL
Intervention: verapamil‐SR
Number of subjects: 22576

Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 22576

Group type: EXPERIMENTAL
Intervention: Class I obesity (BMI 30 to 35 kg/m2)
Number of subjects: 22576

Group type: EXPERIMENTAL
Intervention: Class II to III obesity (BMI 35 kg/m2 or more)
Number of subjects: 22576

Group type: COMPARATOR
Intervention: Normal weight (BMI 20 to<25 kg/m2)
Number of subjects: 22576
Study: 15238028

Group type: EXPERIMENTAL
Intervention: Generation (participants generated some study words, e.g., hot‐c__)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reading (participants read other study words, e.g., hot‐cold)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Generation
Number of subjects: 0
Study: 12877377

Group type: EXPERIMENTAL
Intervention: Antibiotics (amoxicillin 750 mg x 2, doxycycline 100 mg x 2 or penicillin V 1500 mg x 2)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 10584397

Group type: EXPERIMENTAL
Intervention: Nitrox gas mixture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Air
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxygen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrox
Number of subjects: 0

Group type: COMPARATOR
Intervention: Air, Oxygen, Nitrox
Number of subjects: 0
Study: 7784724

Group type: EXPERIMENTAL
Intervention: Lidocaine 1% (1 mg/kg) administered via regular endotracheal tube (group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lidocaine 1% (1 mg/kg) administered via suction-catheter deep endobronchially (group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lidocaine 1% (1 mg/kg) administered via EDGAR-tube (group 3)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (group 4) with regular endotracheal tube without lidocaine administration
Number of subjects: 60
Study: 2113848

Group type: EXPERIMENTAL
Intervention: 300 micrograms norethisterone (NET)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 30 micrograms levonorgestrel (L‐NOG)
Number of subjects: 20
Study: 486293

Group type: EXPERIMENTAL
Intervention: 10 mg metoclopramide
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 20 mg metoclopramide
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Metoclopramide (general)
Number of subjects: 6
Study: 31065703

Group type: EXPERIMENTAL
Intervention: GPM (GalliPro Max/B. subtilis, 500 g/ton)
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: GPT (GalliPro Tect/B. licheniformis, 500 g/ton)
Number of subjects: 384

Group type: COMPARATOR
Intervention: CON (basal diet)
Number of subjects: 384
Study: 28084890

Group type: EXPERIMENTAL
Intervention: Exercise intervention group, median 1.8 h/week during adjuvant therapy (IQR 1.4-2.5)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Exercise intervention group
Number of subjects: 227

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 227

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 227
Study: 26410869

Group type: EXPERIMENTAL
Intervention: Graduated elastic compression stockings (GECS)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Inverse graduated compression stockings (PECS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Comparison of GECS and PECS
Number of subjects: 64
Study: 23402718

Group type: EXPERIMENTAL
Intervention: Counterconditioning (CC) in context A (AAA-COUNTER-group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counterconditioning (CC) in context B (ABA-COUNTER-group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extinction in context B (ABA-EXT-group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counterconditioning (CC)
Number of subjects: 0
Study: 22137072

Group type: COMPARATOR
Intervention: Standard dosing (weight of 121 kg)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Actual body weight (ABW)-based dosing (no upper limit)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Ideal body weight (IBW)-based dosing
Number of subjects: 67
Study: 19387378

Group type: EXPERIMENTAL
Intervention: Walking forward lunges
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Jumping forward lunges
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 32
Study: 17511791

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 0
Study: 15384960

Group type: EXPERIMENTAL
Intervention: TOSCA telescreening procedures for diabetic retinopathy
Number of subjects: 390
Study: 11352416

Group type: EXPERIMENTAL
Intervention: DDAVP (Desmopressin Acetate) administered preoperatively
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 200
Study: 10995074

Group type: EXPERIMENTAL
Intervention: Pancreatic extract (Créon 12,000)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 8044610

Group type: EXPERIMENTAL
Intervention: Chemotherapy (5-fluorouracil, Adriamycin, and mitomycin)
Number of subjects: 43

Group type: COMPARATOR
Intervention: No chemotherapy (Control)
Number of subjects: 43
Study: 31291447

Group type: EXPERIMENTAL
Intervention: High-MUFA diets (conventional canola and high-oleic canola)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Low-MUFA/high-SFA oil blend
Number of subjects: 115
Study: 29276865

Group type: EXPERIMENTAL
Intervention: High frequency oscillatory ventilation (HFO)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CMV)
Number of subjects: 200
Study: 25012156

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 9326

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 9326
Study: 24715012

Group type: EXPERIMENTAL
Intervention: Water and education provision group
Number of subjects: 240

Group type: COMPARATOR
Intervention: Education provision only group
Number of subjects: 240
Study: 21133981

Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (postponed periodontal treatment)
Number of subjects: 50
Study: 19169654

Group type: EXPERIMENTAL
Intervention: Coordinated and tailored work rehabilitation (CTWR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional case management (CCM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CTWR
Number of subjects: 0
Study: 17078443

Group type: EXPERIMENTAL
Intervention: Plum-blossom needle tapping plus modified yangxue dingfeng tang
Number of subjects: 141

Group type: COMPARATOR
Intervention: Modified yangxue dingfeng tang
Number of subjects: 141

Group type: COMPARATOR
Intervention: Oral Benadryl and Vitamin C plus local external application of 10% urea ointment
Number of subjects: 141
Study: 15217172

Group type: EXPERIMENTAL
Intervention: Once daily dosing (ODD) of gentamicin 5 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Twice daily dosing (TDD) of gentamicin 2.5 mg/kg
Number of subjects: 0
Study: 11089713

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers (41%)
Number of subjects: 23748

Group type: EXPERIMENTAL
Intervention: ACE inhibitors (24%)
Number of subjects: 23748

Group type: EXPERIMENTAL
Intervention: Thiazide diuretics (17%)
Number of subjects: 23748

Group type: EXPERIMENTAL
Intervention: Beta-blockers (10%)
Number of subjects: 23748

Group type: COMPARATOR
Intervention: Calcium channel blockers
Number of subjects: 23748
Study: 9291268

Group type: EXPERIMENTAL
Intervention: Clark vestibuloplasty with lyophilized amniotic membrane graft
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Kazanjian vestibuloplasty with lyophilized amniotic membrane graft
Number of subjects: 20
Study: 7911400

Group type: COMPARATOR
Intervention: Lansoprazole 15, 30, or 60 mg/day for 4 and 8 weeks
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 292

Group type: COMPARATOR
Intervention: Lansoprazole
Number of subjects: 292
Study: 2431908

Group type: EXPERIMENTAL
Intervention: meglumine diatrizoate at 306 mgI/ml
Number of subjects: 88

Group type: COMPARATOR
Intervention: iohexol at 240 mgI/ml
Number of subjects: 88
Study: 31502026

Group type: EXPERIMENTAL
Intervention: Zilver PTX drug-eluting stent (DES)
Number of subjects: 1240

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA) or bare metal stent (BMS)
Number of subjects: 1240

Group type: COMPARATOR
Intervention: Bare metal stent (BMS)
Number of subjects: 1240
Study: 29708818

Group type: EXPERIMENTAL
Intervention: 200 mg/day of LI73014F2
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 400 mg/day of LI73014F2
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 27043774

Group type: EXPERIMENTAL
Intervention: Combination therapy (enalapril + aliskiren)
Number of subjects: 7006

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 7006

Group type: COMPARATOR
Intervention: Aliskiren
Number of subjects: 7006
Study: 24924842

Group type: EXPERIMENTAL
Intervention: Pulse ultrasound treatment for popliteal cyamella three times weekly for 8 weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Weekly shock wave therapy for popliteal cyamella for the first 6 weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Isokinetic muscular strengthening exercises three times weekly for 8 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 120
Study: 23252526

Group type: EXPERIMENTAL
Intervention: Canakinumab (4 mg per kilogram, single subcutaneous dose)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Canakinumab (continued treatment)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 100
Study: 21055198

Group type: EXPERIMENTAL
Intervention: Gatifloxacin
Number of subjects: 235

Group type: COMPARATOR
Intervention: Levofloxacin
Number of subjects: 235
Study: 18516715

Group type: EXPERIMENTAL
Intervention: Accelerated means regression models for recurrent event data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Graphical and numerical procedures for model checking
Number of subjects: 0
Study: 15777974

Group type: EXPERIMENTAL
Intervention: EUS-FNA
Number of subjects: 60

Group type: COMPARATOR
Intervention: MS
Number of subjects: 60
Study: 12464461

Group type: EXPERIMENTAL
Intervention: Substance P infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: NaCl infusion (Control)
Number of subjects: 12
Study: 10027502

Group type: EXPERIMENTAL
Intervention: Budesonide and albuterol
Number of subjects: 1041

Group type: EXPERIMENTAL
Intervention: Nedocromil and albuterol
Number of subjects: 1041

Group type: COMPARATOR
Intervention: Placebo and albuterol
Number of subjects: 1041

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 1041
Study: 7560661

Group type: EXPERIMENTAL
Intervention: 12 micrograms formoterol solution
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 24 micrograms formoterol solution
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 12 micrograms formoterol suspension
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fenoterol (400 micrograms)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 24 micrograms formoterol suspension
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All drugs
Number of subjects: 24
Study: 1981218

Group type: EXPERIMENTAL
Intervention: Captopril (ACE inhibitor)
Number of subjects: 7000

Group type: COMPARATOR
Intervention: Control group (no ACE inhibitors)
Number of subjects: 7000
Study: 7000628

Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate tablets
Number of subjects: 28

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 28